Table 1.
Characteristics of study participants
| All | Cancer type | |||||
|---|---|---|---|---|---|---|
| Digestive (C00-C26, C32, C48) |
Gynecologic/Breast (C50-C58) |
Lung/Blood (C33-C31, C81-C96) |
Others | |||
| N | 243 | 86 | 75 | 51 | 31 | |
| Gender | Men | 121 | 60 | 1 | 36 | 24 |
| 49.8% | 69.8% | 1.3% | 70.6% | 77.4% | ||
| Women | 122 | 26 | 74 | 15 | 7 | |
| 50.2% | 30.2% | 98.7% | 29.4% | 22.6% | ||
| Age | 18–64 years | 126 | 30 | 65 | 19 | 12 |
| 51.9% | 34.9% | 86.7% | 37.3% | 38.7% | ||
| 65 + years | 117 | 56 | 10 | 32 | 19 | |
| 48.1% | 65.1% | 13.3% | 62.7% | 61.3% | ||
| Body Mass Index | Underweight (< 18.5) | 39 | 12 | 17 | 8 | 2 |
| 16.0% | 14.0% | 22.7% | 15.7% | 6.5% | ||
| Normal (18.5–24.9) | 148 | 58 | 40 | 33 | 17 | |
| 60.9% | 67.4% | 53.3% | 64.7% | 54.8% | ||
| Overweight (25.0 +) | 56 | 16 | 18 | 10 | 12 | |
| 23.0% | 18.6% | 24.0% | 19.6% | 38.7% | ||
| Chemotherapy | Cytotoxic agents | 129 | 42 | 70 | 5 | 12 |
| 53.1% | 48.8% | 93.3% | 9.8% | 38.7% | ||
| Molecularly targeted agents | 48 | 11 | 0 | 21 | 16 | |
| 19.8% | 12.8% | 0.0% | 41.2% | 51.6% | ||
| Both | 66 | 33 | 5 | 25 | 3 | |
| 27.2% | 38.4% | 6.7% | 49.0% | 9.7% |
Cancer types were classified by the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)